Back
Avid Bioservices Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
51
CDMO
Avid Bioservices
Last Price:
10.60
Seasonality Move:
14.36%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-22.66%
Buy
51
Avid Bioservices (CDMO)
is a Buy
Is Avid Bioservices a Buy, Sell or Hold?
- The current Avid Bioservices [CDMO] share price is $10.57. The Score for CDMO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- CDMO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CDMO Stock Price Chart
What is Avid Bioservices's stock price today?
-
The Avid Bioservices share price today is $10.57
The current trend is moderately bearish and CDMO is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.74
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDMO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 47.19 | Sell |
| Chaikin Money Flow: | 106202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.81 - 11.63) | Sell |
| Bollinger Bands (100): | (7.92 - 10.88) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 59.35 | Buy |
| Chaikin Money Flow: | 187356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.45 - 0.69) | Buy |
| Bollinger Bands (100): | (0.35 - 3.13) | Sell |
CDMO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.07 | Sell |
| 20-day SMA: | 10.96 | Sell |
| 50-day SMA: | 10.65 | Sell |
| 200-day SMA: | 8.18 | Buy |
| 8-day EMA: | 10.99 | Sell |
| 20-day EMA: | 10.94 | Sell |
| 50-day EMA: | 10.43 | Buy |
| 200-day EMA: | 9.28 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.7 | Buy |
| 20-day SMA: | 0.6 | Buy |
| 50-day SMA: | 0.58 | Buy |
| 200-day SMA: | 3.33 | Sell |
| 8-day EMA: | 0.69 | Buy |
| 20-day EMA: | 0.64 | Buy |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 7.62 | Sell |
Avid Bioservices Earnings Growth & CDMO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and an increase next year of $0.02 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Avid Bioservices Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||